Cargando…

Overactive Bladder Disease: The Urge for Better Therapies

Detalles Bibliográficos
Autores principales:	Thomas, Lisa, Culley, Eric J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2008
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438071/ https://www.ncbi.nlm.nih.gov/pubmed/18500915 http://dx.doi.org/10.18553/jmcp.2008.14.4.381

Ejemplares similares

Here Is the Case for the Urge in Administrative Claims Database Research About Overactive Bladder Therapies
por: Szeinbach, Sheryl L., et al.
Publicado: (2008)

Urge suppression and modified fluid consumption in the management of female overactive bladder symptoms
por: Pal, Manidip, et al.
Publicado: (2021)

Impact of mirabegron extended-release on the treatment of overactive bladder with urge urinary incontinence, urgency, and frequency
por: Lee, Raymond T, et al.
Publicado: (2013)

Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence
por: Campbell, Jonathan D, et al.
Publicado: (2009)

Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
por: Zapico, Álvaro, et al.
Publicado: (2023)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
por: Heesakkers, John P. F. A., et al.
Publicado: (2011)

International health library associations urge the ICMJE to seek information specialists as peer reviewers for knowledge synthesis publications
por: Iverson, Sandy, et al.
Publicado: (2021)

Commentary: Extrapleural pneumonectomy during myasthenic crisis: The urge to go big or go home
por: Abbas, Abbas E.
Publicado: (2020)

Increasing reinfections and decreasing effectiveness of COVID-19 vaccines urge the need for vaccine customization
por: Dewan, Syed Masudur Rahman, et al.
Publicado: (2022)

Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems
por: Meng, Lingfeng, et al.
Publicado: (2022)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Refractory overactive bladder: Beyond oral anticholinergic therapy
por: Glinski, Ronald W., et al.
Publicado: (2007)

Drug therapy of overactive bladder - What is coming next?
por: Andersson, Karl-Erik
Publicado: (2015)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
por: Sharaf, Ala’a, et al.
Publicado: (2017)

Long-term adherence to clinical therapy of overactive bladder
por: Drake, Marcus John
Publicado: (2017)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Mediterranean Diet and Overactive Bladder
por: Bozkurt, Yunus Erol, et al.
Publicado: (2022)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

Updates of Overactive Bladder in Pediatrics
por: Shim, Jisung, et al.
Publicado: (2023)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Role of fesoterodine in the treatment of overactive bladder
por: Mansfield, Kylie J
Publicado: (2009)

Recent advances in management of bladder overactivity
por: Smith, Ariana L, et al.
Publicado: (2010)

Botulinum toxin A for the Treatment of Overactive Bladder
por: Hsieh, Po-Fan, et al.
Publicado: (2016)

Third‐line therapy for overactive bladder in the elderly: Nuances and considerations
por: Zillioux, Jacqueline, et al.
Publicado: (2022)

Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome
por: Mu, Hsueh-Yu, et al.
Publicado: (2023)

Dissecting the Urge to Create
por: Andreasen, Nancy C
Publicado: (2004)

Gore Urges Action
Publicado: (1994)

Coexisting overactive–underactive bladder and detrusor overactivity–underactivity in pelvic organ prolapse
por: Frigerio, Matteo, et al.
Publicado: (2022)

The surgical management of the refractory overactive bladder
por: Vasdev, Nikhil, et al.
Publicado: (2010)

Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_5tp8lhrc895unn18o56ol0446f